S22-026 A single cell screening platform for Osteoarthritis drug candidates Stanford inventors have developed a single cell screening platform that can be used to predict the therapeutic effects of osteoarthritis (OA) drugs on individual patients by defining consequent changes in the cellular landscape. Nidhi Bhutani Neety Sahu Fiorella Grandi